278 related articles for article (PubMed ID: 25547663)
21. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
[TBL] [Abstract][Full Text] [Related]
22. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
Hariu CD; Saunders AB; Gordon SG; Norby B; Miller MW
J Vet Cardiol; 2013 Sep; 15(3):197-204. PubMed ID: 23933478
[TBL] [Abstract][Full Text] [Related]
23. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].
Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA
Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
Ettinger SJ; Farace G; Forney SD; Frye M; Beardow A
J Am Vet Med Assoc; 2012 Jan; 240(2):171-80. PubMed ID: 22217025
[TBL] [Abstract][Full Text] [Related]
25. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
Schmidt MK; Reynolds CA; Estrada AH; Prosek R; Maisenbacher HW; Sleeper MM; Oyama MA
J Vet Cardiol; 2009 May; 11 Suppl 1():S81-6. PubMed ID: 19394913
[TBL] [Abstract][Full Text] [Related]
26. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
[TBL] [Abstract][Full Text] [Related]
27. [Factors associated plasma B type natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels].
Chen Y; Yao CL; Shimada T
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):825-30. PubMed ID: 19102867
[TBL] [Abstract][Full Text] [Related]
28. Analytical validation of an immunoassay for the quantification of N-terminal pro-B-type natriuretic peptide in feline blood.
Mainville CA; Clark GH; Esty KJ; Foster WM; Hanscom JL; Hebert KJ; Lyons HR
J Vet Diagn Invest; 2015 Jul; 27(4):414-21. PubMed ID: 26077545
[TBL] [Abstract][Full Text] [Related]
29. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
30. Relationship between N-terminal pro-B-type natriuretic peptide (Nt-proBNP) and cardiac cycle efficiency in cardiac surgery.
Scolletta S; Ranaldi G; Carlucci F; Franchi F; Romano SM; Biagioli B
Biomed Pharmacother; 2010 Oct; 64(8):511-5. PubMed ID: 20137881
[TBL] [Abstract][Full Text] [Related]
31. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers.
Collinson PO; Barnes SC; Gaze DC; Galasko G; Lahiri A; Senior R
Eur J Heart Fail; 2004 Mar; 6(3):365-8. PubMed ID: 14987590
[TBL] [Abstract][Full Text] [Related]
32. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
[TBL] [Abstract][Full Text] [Related]
34. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
36. N-terminal pro-B-type natriuretic peptide: a potential marker of fetal heart failure in hemolytic disease.
Luterek K; Szymusik I; Bartkowiak R; Koltowski L; Filipiak KJ; Wielgos M
Neuro Endocrinol Lett; 2011; 32(5):657-62. PubMed ID: 22167142
[TBL] [Abstract][Full Text] [Related]
37. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
[TBL] [Abstract][Full Text] [Related]
38. Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.
Lin CW; Zeng XL; Zhang JF; Meng XH
J Card Fail; 2014 Mar; 20(3):168-73. PubMed ID: 24361777
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
40. [Effect of nasal intermittent positive pressure ventilation on N-terminal pro-brain natriuretic peptide in patients with acute exacerbations of chronic obstructive pulmonary disease and type II respiratory failure].
Wang Y; Yang Y; Chen P; Luo Y; Yang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):325-31. PubMed ID: 22561561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
